Search

everythinglearnresearchcommunity

for

Search:↓

Flutamide and a new synthetic steroid affected brain and prostate chemicals and showed potential for treating androgen-related conditions and epilepsy.

Women with hair loss had higher levels of certain hormones, suggesting a link to a condition like PCOS.

DHEA stimulates skin oil glands and could help postmenopausal women, with potential for acne and excessive hair growth treatments.

Four new compounds were more effective than finasteride in treating prostate issues and hair loss, with one being 100 times more active and safe for use.

New sulfur-containing steroid analogs show promise for more targeted medical treatments.

Some newly made compounds are promising for treating enlarged prostate, hair loss, viruses, and prostate cancer, and might be better than current drugs.

New compounds show promise for treating hair loss, enlarged prostate, and prostate cancer, with some being more effective and having different side effects than current treatments.

11α-Hydroxyprogesterone is changed into different substances by certain enzymes and may play a role in prostate cancer.

New steroids were effective in blocking male hormone receptors in hamster prostates.

Finasteride doesn't affect ovulation in normal women.

Adding anti-Müllerian hormone to PCOS criteria lowers the number of women diagnosed.

High-dose dutasteride reduces PMDD symptoms by stabilizing neurosteroid levels.

C60 fullerenes can alter protein function and may help develop new disease inhibitors.

Lower SHBG levels may increase the risk of PCOS.

Women with PCOS have more body fat and thicker fat layers in certain abdominal areas than women without PCOS.

DHEA did not improve sexual function, well-being, or menopausal symptoms in postmenopausal women with low libido but caused side effects like acne and increased facial hair.

Finasteride and flutamide effectively reduce hirsutism in PCOS women, with flutamide also lowering hormone levels.

Testosterone therapy is beneficial for women's health and does not cause masculinization or liver damage, and it protects the heart and breasts.

Shorter CAG repeats in a specific gene may increase male hormone activity and symptoms like acne and excess hair in women with PCOS.

Taking spironolactone and linestrenol for androgen excess can lead to lower bone density in young women.

New androgen receptor modulators show promise for treating diseases like prostate cancer and muscle wasting.

17α-Estradiol solution safely improves hair density and thickness in female pattern hair loss.

New research is needed to create better drugs that block the enzyme responsible for conditions like male baldness and prostate enlargement.

Neurosteroids can influence behavior by modulating brain inhibition, with potential for treating psychiatric disorders.

Women with AGA have more androstenedione and dihydrotestosterone, less copper and zinc; copper imbalance affects AGA; treatment improves hormones and minerals.

High fasting insulin levels in women with PCOS are linked to a higher risk of heart and metabolic problems.

The more lipophilic the progesterone derivative, the better it binds to androgen receptors and has antiandrogenic effects.

MENT could be a better option than testosterone for male hormone therapy and birth control because it works well at lower doses and has fewer side effects on the prostate.

Skin changes can indicate hormonal imbalances and help diagnose endocrine disorders.

We need better ways to test and understand SARMs to make safer and more effective treatments.